<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/acrv" ></link>
<id>urn:uuid:4164105d-f4b6-e2cc-7abb-c41531562a89</id>
<updated>2026-05-03T22:19:53-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ACRV: RA CAPITAL MANAGEMENT L P (DIR,BO) Acquired (JB) 3.9mm Shares of ACRIVON THERAPEUTICS INC for $1.80 on 4/22</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6389982" ></link>
<id>urn:uuid:5fe634b1-6317-da49-1c7f-77ae349c9215</id>
<updated>2026-04-23T16:28:10-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: MILLER MARY (LO) Disposed (JS) 558 Shares of ACRIVON THERAPEUTICS INC for $1.78 on 4/17</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6389083" ></link>
<id>urn:uuid:38f46b57-a1fa-00dc-a0ba-9110d5e97597</id>
<updated>2026-04-21T17:05:48-04:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Disposed (JS) 14,265 Shares of ACRIVON THERAPEUTICS INC for $1.53 on 2/21</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6338304" ></link>
<id>urn:uuid:5f1aa180-cd26-cf4c-881b-9b5e250271e5</id>
<updated>2026-02-24T16:12:46-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: PETERSON KATHARINE (CAO) Disposed (JS) 116 Shares of ACRIVON THERAPEUTICS INC for $1.63 on 2/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6331167" ></link>
<id>urn:uuid:a33ae906-7251-7742-9989-11eff96422d2</id>
<updated>2026-02-18T16:14:35-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: MILLER MARY (LO) Disposed (JS) 217 Shares of ACRIVON THERAPEUTICS INC for $1.63 on 2/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6331166" ></link>
<id>urn:uuid:ccc1aef2-4f8c-3177-9fd5-bb1748783b00</id>
<updated>2026-02-18T16:12:42-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: GAMELIN ERICK (O) Disposed (JS) 471 Shares of ACRIVON THERAPEUTICS INC for $1.63 on 2/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6331153" ></link>
<id>urn:uuid:ebaf454a-342e-9fb2-a96d-090b6faec306</id>
<updated>2026-02-18T16:11:58-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: DEVROE ERIC (COO) Disposed (JS) 723 Shares of ACRIVON THERAPEUTICS INC for $1.63 on 2/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6331132" ></link>
<id>urn:uuid:62a320fc-4390-a060-6162-84dc484af830</id>
<updated>2026-02-18T16:10:45-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Disposed (JS) 1,302 Shares of ACRIVON THERAPEUTICS INC for $1.63 on 2/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6331108" ></link>
<id>urn:uuid:bdb82378-5f3e-6b6c-91c9-cd9bb6ca96ef</id>
<updated>2026-02-18T16:09:33-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: BLUME JENSEN PETER (PR,CEO,DIR) Disposed (JS) 579 Shares of ACRIVON THERAPEUTICS INC for $1.63 on 2/14</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6331109" ></link>
<id>urn:uuid:adb733b7-da96-9dfa-d952-024d583d353f</id>
<updated>2026-02-18T16:09:33-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
<entry>
<title>ACRV: MILLER MARY (LO) Disposed (JS) 659 Shares of ACRIVON THERAPEUTICS INC for $1.98 on 1/17</title>
<link href="http://www.insiderinsights.com/company/acrv/acrivon-therapeutics-inc/id-6310681" ></link>
<id>urn:uuid:1674aa45-6bde-54f7-0780-85496c57428f</id>
<updated>2026-01-21T16:02:10-05:00</updated>
<summary type="html" ><![CDATA[ACRIVON THERAPEUTICS INC (ACRV). Recent Price: $1.81. Mkt Cap:70.1mm. 10D Vol: 1.2mm]]></summary>
</entry>
</feed>